株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

非侵襲性出生前診断 (NIPT) の世界市場:2017〜2021年

Global Non-invasive Prenatal Testing Market 2017-2021

発行 TechNavio (Infiniti Research Ltd.) 商品コード 369186
出版日 ページ情報 英文 86 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.28円で換算しております。
Back to Top
非侵襲性出生前診断 (NIPT) の世界市場:2017〜2021年 Global Non-invasive Prenatal Testing Market 2017-2021
出版日: 2017年11月02日 ページ情報: 英文 86 Pages
概要

世界の非侵襲性出生前診断 (NIPT) 市場は2017〜2021年にかけ16.86%のCAGR (年間複合成長率) で拡大するとみられています。

当レポートでは、世界の非侵襲性出生前診断市場について調査し、アプリケーション、エンドユーザー、および地域別の動向、今後の成長見通しとともに、市場に参入する主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの調査範囲

第3章 市場調査方法

第4章 イントロダクション

第5章 市況

  • 概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 区分:アプリケーション別

  • 概要
  • トリソミー
  • 微小欠失
  • その他

第7章 区分:エンドユーザー別

  • 概要
  • 診断センター
  • 病院

第8章 区分:地域別

  • 概要
  • 地域比較
  • 南北アメリカにおけるNIPT市場
  • 欧州・中東・アフリカにおけるNIPT市場
  • アジア太平洋地域におけるNIPT市場
  • 主要諸国
  • 市場機会

第9章 意思決定の枠組み

最10章 促進因子・課題 ▼市場成長促進因子 ▼市場課題

第11章 市場動向

  • NIPTの採用が拡大
  • 遺伝子カウンセリングの増加
  • 出生時における遺伝子スクリーニングプログラムの拡大

第12章 ベンダー情勢

  • 競合状況
  • 投資機会

第13章 主要ベンダーの分析

  • BGI Genomics
  • Illumina
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics
  • その他の有望ベンダー

第14章 付録

図表リスト

図表
  • Exhibit 01: Types of prenatal diagnosis and screening
  • Exhibit 02: Lifecycle of prenatal testing techniques
  • Exhibit 03: Comparative analysis of NIPT with other techniques
  • Exhibit 04: Global NIPT market: Overview 2017-2021
  • Exhibit 05: Global NIPT market 2016-2021 ($ millions)
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Global NIPT market: Segmentation by application 2016 (% share)
  • Exhibit 08: Global NIPT market: Segmentation by application 2021 (% share)
  • Exhibit 09: Global NIPT market: Segmentation by application 2016-2021 (% share)
  • Exhibit 10: Global NIPT by trisomy market 2016-2021 ($ millions)
  • Exhibit 11: Global NIPT by microdeletions market 2016-2021 ($ millions)
  • Exhibit 12: Global NIPT by others market 2016-2021 ($ millions)
  • Exhibit 13: Global NIPT market: Segmentation by end-user 2016-2021 (% share)
  • Exhibit 14: Global NIPT market by diagnostic centers 2016-2021 ($ millions)
  • Exhibit 15: Global NIPT market by hospitals 2016-2021 ($ millions)
  • Exhibit 16: Global NIPT market: Segmentation by geography 2016-2021 (% share)
  • Exhibit 17: Global NIPT market: Regional comparison
  • Exhibit 18: NIPT market in Americas 2016-2021($ millions)
  • Exhibit 19: NIPT market in Americas: Year-over-year growth 2017-2021 (%)
  • Exhibit 20: NIPT market in EMEA 2016-2021 ($ millions)
  • Exhibit 21: NIPT market in EMEA: Year-over-year growth (%) (2017-2021)
  • Exhibit 22: NIPT market in APAC 2016-2021 ($ million)
  • Exhibit 23: NIPT market in APAC: Year-over-year growth 2017-2021 (%)
  • Exhibit 24: Global NIPT market: Key leading countries
  • Exhibit 25: Global NIPT market: Growth and success factors of vendors
  • Exhibit 26: Global NIPT market: Investment opportunity mapping
  • Exhibit 27: BGI Genomics: Overview
  • Exhibit 28: BGI Genomics: Strength analysis
  • Exhibit 29: BGI Genomics: Strategy assessment
  • Exhibit 30: BGI Genomics opportunity assessment
  • Exhibit 31: Illumina: Overview
  • Exhibit 32: Illumina: Strength analysis
  • Exhibit 33: Illumina: Strategy assessment
  • Exhibit 34: Illumina: Opportunity assessment
  • Exhibit 35: Laboratory Corporation of America Holdings: Overview
  • Exhibit 36: Laboratory Corporation of America Holdings: Strength analysis
  • Exhibit 37: Laboratory Corporation of America Holdings: Strategy assessment
  • Exhibit 38: Laboratory Corporation of America Holdings: Opportunity assessment
  • Exhibit 39: Quest Diagnostics Overview
  • Exhibit 40: Quest Diagnostics: Strength analysis
  • Exhibit 41: Quest Diagnostics: Strategy assessment
  • Exhibit 42: Quest Diagnostics: Opportunity assessment
目次
Product Code: IRTNTR15498

About Non-invasive Prenatal Testing

Non-invasive prenatal screening is performed primarily by ultrasonography and serum testing from maternal plasma. Ultrasonography uses the clear tissue behind the infant's neck to detect genetic defects. A fetus with abnormalities tends to accumulate more fluid. Hence, more clear space is detected behind the neck, which is an indicative measure. Maternal serum screening is a method that involves blood testing in the first and second trimester of the gestation period where specific chemicals such as pregnancy-associated plasma protein A (PAPP-A) and free beta human chorionic gonadotropin (HCG) are checked.

Technavio's analysts forecast the global non-invasive prenatal testing market to grow at a CAGR of 16.86% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global non-invasive prenatal testing market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Non-invasive Prenatal Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • BGI Genomics
  • Illumina
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics

Other Prominent Vendors

  • Agilent Technologies
  • Berry Genomics
  • F. Hoffman-La Roche
  • LifeCodexx
  • Natera
  • PerkinElmer

Market driver

  • Advantages of non-invasive methods over invasive methods
  • For a full, detailed list, view our report

Market challenge

  • Abortion rate and ethical hurdles
  • For a full, detailed list, view our report

Market trend

  • Increase in acceptance of NIPT
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

  • Overview

PART 05: MARKET LANDSCAPE

  • Overview
  • Market size and forecast
  • Five forces analysis

PART 06: SEGMENTATION BY APPLICATION

  • Overview
  • Trisomy
  • Microdeletions
  • Others

PART 07: SEGMENTATION BY END-USER

  • Overview
  • Diagnostic centers
  • Hospitals

PART 08: SEGMENTATION BY GEOGRAPHY

  • Overview
  • Regional comparison
  • NIPT market in Americas
  • NIPT market in EMEA
  • NIPT market in APAC
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Increase in acceptance of NIPT
  • Increase in genetic counseling
  • Growth of genetic screening programs at births

PART 12: VENDOR LANDSCAPE

  • Competitive scenario
  • Investment opportunities

PART 13: KEY VENDOR ANALYSIS

  • BGI Genomics
  • Illumina
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics
  • Other prominent vendors

PART 14: APPENDIX

  • List of abbreviations
Back to Top